137 related articles for article (PubMed ID: 19924140)
1. Seroreactivity of 38 human papillomavirus types in epidermodysplasia verruciformis patients, relatives, and controls.
Michael KM; Waterboer T; Pfister H; Gariglio M; Majewski S; Favre M; Pawlita M
J Invest Dermatol; 2010 Mar; 130(3):841-8. PubMed ID: 19924140
[TBL] [Abstract][Full Text] [Related]
2. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer.
Feltkamp MC; Broer R; di Summa FM; Struijk L; van der Meijden E; Verlaan BP; Westendorp RG; ter Schegget J; Spaan WJ; Bouwes Bavinck JN
Cancer Res; 2003 May; 63(10):2695-700. PubMed ID: 12750299
[TBL] [Abstract][Full Text] [Related]
3. High beta-HPV DNA loads and strong seroreactivity are present in epidermodysplasia verruciformis.
Dell'Oste V; Azzimonti B; De Andrea M; Mondini M; Zavattaro E; Leigheb G; Weissenborn SJ; Pfister H; Michael KM; Waterboer T; Pawlita M; Amantea A; Landolfo S; Gariglio M
J Invest Dermatol; 2009 Apr; 129(4):1026-34. PubMed ID: 18923444
[TBL] [Abstract][Full Text] [Related]
4. Sunlight exposure and (sero)prevalence of epidermodysplasia verruciformis-associated human papillomavirus.
Termorshuizen F; Feltkamp MC; Struijk L; de Gruijl FR; Bavinck JN; van Loveren H
J Invest Dermatol; 2004 Jun; 122(6):1456-62. PubMed ID: 15175037
[TBL] [Abstract][Full Text] [Related]
5. Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses.
Orth G
Semin Immunol; 2006 Dec; 18(6):362-74. PubMed ID: 17011789
[TBL] [Abstract][Full Text] [Related]
6. Epidermodysplasia verruciformis-associated and genital-mucosal high-risk human papillomavirus DNA are prevalent in nevus sebaceus of Jadassohn.
Carlson JA; Cribier B; Nuovo G; Rohwedder A
J Am Acad Dermatol; 2008 Aug; 59(2):279-94. PubMed ID: 18638629
[TBL] [Abstract][Full Text] [Related]
7. Detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in nongenital seborrhoeic keratosis.
Li YH; Chen G; Dong XP; Chen HD
Br J Dermatol; 2004 Nov; 151(5):1060-5. PubMed ID: 15541085
[TBL] [Abstract][Full Text] [Related]
8. High frequency of detection of human papillomaviruses associated with epidermodysplasia verruciformis in children with psoriasis.
Mahé E; Bodemer C; Descamps V; Mahé I; Crickx B; De Prost Y; Favre M
Br J Dermatol; 2003 Oct; 149(4):819-25. PubMed ID: 14616375
[TBL] [Abstract][Full Text] [Related]
9. [Polyclonal antibody to human papillomavirus-related antigens specific to epidermodysplasia verruciformis].
Ishiji T
Nihon Hifuka Gakkai Zasshi; 1989 May; 99(6):683-95. PubMed ID: 2479785
[TBL] [Abstract][Full Text] [Related]
10. Psoriasis: A possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis.
Favre M; Orth G; Majewski S; Baloul S; Pura A; Jablonska S
J Invest Dermatol; 1998 Apr; 110(4):311-7. PubMed ID: 9540967
[TBL] [Abstract][Full Text] [Related]
11. Detection of antibodies against epidermodysplasia verruciformis-associated canine papillomavirus 3 in sera of dogs from Europe and Africa by enzyme-linked immunosorbent assay.
Lange CE; Tobler K; Favrot C; Müller M; Nöthling JO; Ackermann M
Clin Vaccine Immunol; 2009 Jan; 16(1):66-72. PubMed ID: 19038784
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA.
Weissenborn SJ; Höpfl R; Weber F; Smola H; Pfister HJ; Fuchs PG
J Invest Dermatol; 1999 Jul; 113(1):122-6. PubMed ID: 10417630
[TBL] [Abstract][Full Text] [Related]
13. The presence of antibodies against virus-like particles of epidermodysplasia verruciformis-associated humanpapillomavirus type 8 in patients with actinic keratoses.
Bouwes Bavinck JN; Stark S; Petridis AK; Marugg ME; Ter Schegget J; Westendorp RG; Fuchs PG; Vermeer BJ; Pfister H
Br J Dermatol; 2000 Jan; 142(1):103-9. PubMed ID: 10651702
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of human papillomavirus antibodies in young female subjects in England.
Jit M; Vyse A; Borrow R; Pebody R; Soldan K; Miller E
Br J Cancer; 2007 Oct; 97(7):989-91. PubMed ID: 17726462
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for cutaneous human papillomavirus seroreactivity among patients undergoing skin cancer screening in Florida.
Iannacone MR; Michael KM; Giuliano AR; Waterboer T; Pawlita M; Rollison DE
J Infect Dis; 2010 Mar; 201(5):760-9. PubMed ID: 20105078
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin.
Harwood CA; Surentheran T; Sasieni P; Proby CM; Bordea C; Leigh IM; Wojnarowska F; Breuer J; McGregor JM
Br J Dermatol; 2004 May; 150(5):949-57. PubMed ID: 15149508
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population.
Pfister H; Fuchs PG; Majewski S; Jablonska S; Pniewska I; Malejczyk M
Arch Dermatol Res; 2003 Dec; 295(7):273-9. PubMed ID: 14618345
[TBL] [Abstract][Full Text] [Related]
18. Acquired epidermodysplasia verruciformis.
Rogers HD; Macgregor JL; Nord KM; Tyring S; Rady P; Engler DE; Grossman ME
J Am Acad Dermatol; 2009 Feb; 60(2):315-20. PubMed ID: 19150275
[TBL] [Abstract][Full Text] [Related]
19. A human papillomavirus-associated disease with disseminated warts, depressed cell-mediated immunity, primary lymphedema, and anogenital dysplasia: WILD syndrome.
Kreuter A; Hochdorfer B; Brockmeyer NH; Altmeyer P; Pfister H; Wieland U;
Arch Dermatol; 2008 Mar; 144(3):366-72. PubMed ID: 18347293
[TBL] [Abstract][Full Text] [Related]
20. [Pathogenesis of human papillomavirus infection in patients with epidermodysplasia verruciformis].
Liang S; Zuo YG; Wang BX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):93-6. PubMed ID: 19317070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
